Are prolactin levels efficient in predicting a pituitary lesion in patients with hyperprolactinemia?

• DOI: 10.1007/s12020-023-03678-z
• Publication Date: 2024-01-09T08:02:14Z
• Authors: Emanuele Varaldo; Daniela Cuboni; Nunzia Prencipe; Luigi Simone Aversa; Michela Sibilla; Fabio Bioletto; Alessandro Maria ...; Valentina Gasco; Ezio Ghigo; Silvia Grottoli
• Keywords: Male; Adult; Adolescent; Pituitary Diseases; Middle Aged; Magnetic Resonance Imaging; Prolactin; Hyperprolactinemia; Young Adult; 03 medical and health sciences; 0302 clinical medicine; Pituitary Gland; Humans; Original Article; Female; Pituitary Neoplasms; Retrospective Studies; Aged

Abstract Purpose Data regarding the presence of a prolactin (PRL) threshold above which a pituitary magnetic resonance imaging (MRI) is mandatory in patients with hyperprolactinemia (hyperPRL) are controversial and derived primarily from studies focused on female populations. Aim of our study was to evaluate in a cohort of patients of both sexes with confirmed hyperPRL, the possible correlation between PRL values and the presence of pituitary abnormalities.

Methods We retrospectively analyzed data from patients who underwent serial PRL sampling at our Division between January 2015 and December 2022. Patients diagnosed with monomeric hyperPRL at serial sampling and with subsequent contrast-enhanced MRI results available for the pituitary region were included in the study. Exclusion criteria were prior pituitary disease, severe renal insufficiency, liver cirrhosis, uncompensated primary hypothyroidism and ongoing therapy with hyperprolactinemic drugs. Physiological causes of hyperPRL were also ruled out.

Results Out of the 1253 patients who underwent serial PRL sampling, 139 patients (101 women and 38 men) met the inclusion criteria: 106 (76.3%) patients had some form of pituitary disease, with microlesions observed in 69.8%, macrolesions in 25.5% and other findings in 4.7% of subjects. PRL values showed a modest accuracy in predicting the presence of a pituitary abnormality and the best cut-offs identified were >25 µg/L (AUC 0.767, p = 0.003) and >44.2 µg/L (AUC 0.697, p < 0.001) in men and women, respectively; however, if only patients with PRL values > 500 µg/L were excluded from the analysis, as they were already supposed to harbor a macroprolactinoma, PRL levels were not able to predict the presence of a macrolesion neither in men nor women.

Conclusion Given the high prevalence of pituitary abnormalities in patients of both sexes with hyperPRL at serial sampling, performing a pituitary imaging in all cases of hyperPRL, even if mild, appears to be a cautious choice.